Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
|
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
|---|---|---|---|---|---|---|---|---|---|
| TGCT | rs35777021 | chr19:37910991 | C/T | 1.37E-13 | 134 | 45.47 | 37.53 | 17.1 | KM Plot |
| TGCT | rs35789143 | chr7:128727730 | G/A | 2.02E-5 | 132 | 42.18 | 37.1 | 17.1 | KM Plot |
| TGCT | rs35796318 | chr4:47425923 | A/G | 0.000163 | 130 | 46.3 | 34.23 | 51.6 | KM Plot |
| TGCT | rs35880599 | chr2:3480855 | A/T | 2.43E-5 | 131 | 40.57 | 75.38 | 25.32 | KM Plot |
| TGCT | rs35931272 | chr10:27557719 | A/G | 6.98E-7 | 132 | 42.18 | 46.3 | 20.6 | KM Plot |
| TGCT | rs36072475 | chr6:42594068 | T/TA | 2.13E-7 | 132 | 38.2 | 45.1 | 23.82 | KM Plot |
| TGCT | rs36073657 | chr7:128651522 | C/T | 1.69E-5 | 134 | 42.27 | 30.3 | 17.1 | KM Plot |
| TGCT | rs369538927 | chr7:127210009 | AATGG/A | 6.53E-13 | 127 | 42.03 | 30.88 | 17.1 | KM Plot |
| TGCT | rs371374 | chr17:39381828 | A/C | 7.83E-7 | 132 | 13.17 | 56.7 | 42.27 | KM Plot |
| TGCT | rs371517139 | chr6:62817828 | C/T | 7.8E-7 | 133 | 42.18 | 38.2 | 23.43 | KM Plot |
| TGCT | rs371823452 | chr17:39384032 | G/GA | 1.16E-6 | 129 | 13.17 | 56.7 | 42.18 | KM Plot |
| TGCT | rs373255459 | chr3:125630907 | CTTATT/C | 2.17E-5 | 132 | 51.32 | 35.37 | 52.43 | KM Plot |
| TGCT | rs3736745 | chr6:42630107 | A/G | 2.46E-8 | 134 | 37.62 | 51.67 | 20.6 | KM Plot |
| TGCT | rs3741615 | chr12:129298848 | G/A | 1.39E-5 | 134 | 41.33 | 44.28 | 29.53 | KM Plot |
| TGCT | rs374433840 | chr10:27593768 | T/C | 0 | 127 | 42.18 | 45.83 | 18.85 | KM Plot |